Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05115890 · ClinicalTrials.gov registry record · NA
Muscle Blood Flow Regulation in HFpEF
A NA study of HFpEF, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT05115890 is a NA study of HFpEF that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 35 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05115890, a NA study of HFpEF, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
Heart failure with preserved ejection (HFpEF) disproportionately affects Veterans and is the number one reason for hospital discharge in the VA Health Care System. Exercise intolerance is a common complication experienced by patients with HFpEF, perpetuating physical inactivity and accelerating disease progression. This research proposal aims to elucidate mechanisms responsible for inadequate skeletal muscle blood flow and exercise intolerance in patients with HFpEF compared with healthy controls as well as following 8 weeks of exercise training in patients with HFpEF only.
Conditions Studied
Interventions
- OTHER Exercise training
Study Locations (1)
Utah
- VA Salt Lake City Health Care System, Salt Lake City, UT - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2022-07-01 |
| Est. Completion | 2028-02-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05115890
The ClinicalTrials.gov registry entry for NCT05115890 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with HFpEF appearing as the primary indexed condition, and to 1 intervention - of which Exercise training is the first listed.
NCT05115890 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT05115890 about?
NCT05115890 is a clinical study titled "Muscle Blood Flow Regulation in HFpEF". Heart failure with preserved ejection (HFpEF) disproportionately affects Veterans and is the number one reason for hospital discharge in the VA Health Care System. Exercise intolerance is a common complication experienced by patients with HFpEF, perpetuating physical inactivity and accelerating dise...
What is the current status of trial NCT05115890?
This trial is currently recruiting. It is a NA study. The enrollment target is 35 participants. The study started on 2022-07-01. Estimated completion is 2028-02-29.
What conditions does trial NCT05115890 study?
This clinical trial studies the following conditions: HFpEF.
What interventions are being tested in trial NCT05115890?
The interventions under investigation include: Exercise training (OTHER).
Who is sponsoring clinical trial NCT05115890?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05115890 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.